Literature DB >> 11377168

Inhibition of the HIV-1 rev-RRE complex formation by unfused aromatic cations.

G Xiao1, A Kumar, K Li, C T Rigl, M Bajic, T M Davis, D W Boykin, W D Wilson.   

Abstract

RNA viruses cause a wide range of human diseases. Development of new agents to target such viruses is an active area of research. Towards this goal, a series of diphenylfuran cations as potential inhibitors of the Rev-RRE complex have been designed and synthesized. Analysis of the interaction of the diphenylfurans with RRE and TAR RNA model systems by gel shift assays indicates that they exhibit both sequence and structure-dependent binding modes. Our results show a strong interaction between the diphenylfuran ring system and RRE bases, while the TAR interactions are much weaker with the compounds that are the best inhibitors of Rev-RRE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377168     DOI: 10.1016/s0968-0896(00)00344-8

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  12 in total

1.  A reporter based single step assay for evaluation of inhibitors targeting HIV-1 Rev-RRE interaction.

Authors:  Sumeer Raina; Ajit G Chande; Masanori Baba; Robin Mukhopadhyaya
Journal:  Virusdisease       Date:  2013-09-27

2.  Discovery of Small Molecule Ligands for MALAT1 by Tuning an RNA-Binding Scaffold.

Authors:  Anita Donlic; Brittany S Morgan; Jason L Xu; Anqi Liu; Carlos Roble; Amanda E Hargrove
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-10       Impact factor: 15.336

3.  Small molecule-RNA targeting: starting with the fundamentals.

Authors:  Amanda E Hargrove
Journal:  Chem Commun (Camb)       Date:  2020-11-26       Impact factor: 6.222

4.  Dynamic ensemble of HIV-1 RRE stem IIB reveals non-native conformations that disrupt the Rev-binding site.

Authors:  Chia-Chieh Chu; Raphael Plangger; Christoph Kreutz; Hashim M Al-Hashimi
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

5.  Biosensor-surface plasmon resonance: A strategy to help establish a new generation RNA-specific small molecules.

Authors:  Tam Vo; Ananya Paul; Arvind Kumar; David W Boykin; W David Wilson
Journal:  Methods       Date:  2019-05-09       Impact factor: 3.608

6.  Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.

Authors:  Deidra Shuck-Lee; Fei Fei Chen; Ryan Willard; Sharmila Raman; Roger Ptak; Marie-Louise Hammarskjold; David Rekosh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

7.  Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNA.

Authors:  Jessica E Wynn; Wenyu Zhang; Denis M Tebit; Laurie R Gray; Marie-Louise Hammarskjold; David Rekosh; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2016-04-05       Impact factor: 3.641

8.  Targeting folded RNA: a branched peptide boronic acid that binds to a large surface area of HIV-1 RRE RNA.

Authors:  Wenyu Zhang; David I Bryson; Jason B Crumpton; Jessica Wynn; Webster L Santos
Journal:  Org Biomol Chem       Date:  2013-10-07       Impact factor: 3.876

9.  A new HIV-1 Rev structure optimizes interaction with target RNA (RRE) for nuclear export.

Authors:  Norman R Watts; Elif Eren; Xiaolei Zhuang; Yun-Xing Wang; Alasdair C Steven; Paul T Wingfield
Journal:  J Struct Biol       Date:  2018-03-29       Impact factor: 2.867

10.  Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR.

Authors:  Neeraj N Patwardhan; Laura R Ganser; Gary J Kapral; Christopher S Eubanks; Janghyun Lee; Bharathwaj Sathyamoorthy; Hashim M Al-Hashimi; Amanda E Hargrove
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.